Related Experiment Video
Updated: Aug 10, 2026
12:17
Construction and Implantation of a Microinfusion System for Sustained Delivery of Neuroactive Agents.
Published on: March 17, 2008
In Vivo Validation of a Mechanically Adaptive Microfluidic Intracortical Device as a Platform for Sustained Local
Youjoung Kim1,2, Lindsey N Druschel1,2, Natalie Mueller1,2
1Case Western Reserve University, United States.
Frontiers in Biomaterials Science
|August 8, 2026
Summary
New brain-computer interface probes using cellulose nanocrystal composites show reduced neural inflammation. This technology may enable future drug delivery to improve brain-computer interface performance.
Area of Science:
- Biomaterials Science
- Neuroscience
- Medical Devices
Background:
- Intracortical microelectrodes (IMEs) are crucial for brain-computer interfaces (BCIs).
- Implanted IMEs suffer performance degradation due to chronic inflammation and tissue response.
- Developing compliant materials is key to mitigating neural inflammation and improving IME longevity.
Purpose of the Study:
- To evaluate the tissue response of a novel mechanically adaptive microfluidic probe made from cellulose nanocrystal (CNC) polymer nanocomposite.
- To compare the inflammatory and oxidative stress response of the CNC probe against industry standards.
- To establish the potential of this adaptive probe as a platform for therapeutic delivery to reduce neural inflammation.
Main Methods:
- Fabrication of mechanically adaptive microfluidic probes using a CNC polymer nanocomposite.
- Surgical implantation of probes in a rodent model.
- RNA expression analysis to quantify neural inflammation and oxidative stress markers at 4 and 8 weeks post-implantation.
- Comparison with control (naïve) and sham tissue groups.
Main Results:
- The CNC polymer nanocomposite probe demonstrated a comparable tissue response to the industry standard.
- RNA expression analysis indicated manageable levels of neural inflammation and oxidative stress.
- No significant adverse tissue reactions were observed at 4 and 8 weeks post-implantation.
Conclusions:
- The developed mechanically adaptive CNC probe shows promise as a biocompatible platform for brain-computer interfaces.
- The probe's design facilitates potential future integration with drug delivery systems for therapeutic interventions.
- This technology could significantly improve the long-term performance and reliability of brain-computer interfaces by managing neural inflammation.
